159 related articles for article (PubMed ID: 32052215)
1. Fibrolamellar Hepatocellular Carcinoma: A Population-Based Observational Study.
Ramai D; Ofosu A; Lai JK; Gao ZH; Adler DG
Dig Dis Sci; 2021 Jan; 66(1):308-314. PubMed ID: 32052215
[TBL] [Abstract][Full Text] [Related]
2. Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective.
Mayo SC; Mavros MN; Nathan H; Cosgrove D; Herman JM; Kamel I; Anders RA; Pawlik TM
J Am Coll Surg; 2014 Feb; 218(2):196-205. PubMed ID: 24315886
[TBL] [Abstract][Full Text] [Related]
3. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
4. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
5. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
Bhaijee F; Locketz ML; Krige JE
S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
[TBL] [Abstract][Full Text] [Related]
6. The prognosis of fibrolamellar carcinoma versus conventional hepatocellular carcinoma: a study based on propensity score matching.
Qiu S; Chen R; Hu J; Han T
Scand J Gastroenterol; 2023; 58(11):1351-1358. PubMed ID: 37353942
[TBL] [Abstract][Full Text] [Related]
7. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature.
Alshareefy Y; Shen CY; Prekash RJ
Pathol Res Pract; 2023 Aug; 248():154655. PubMed ID: 37429175
[TBL] [Abstract][Full Text] [Related]
8. Combined Hepatocellular Cholangiocarcinoma: A Population-Based Retrospective Study.
Ramai D; Ofosu A; Lai JK; Reddy M; Adler DG
Am J Gastroenterol; 2019 Sep; 114(9):1496-1501. PubMed ID: 31335362
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma.
Moreno-Luna LE; Arrieta O; García-Leiva J; Martínez B; Torre A; Uribe M; León-Rodríguez E
BMC Cancer; 2005 Oct; 5():142. PubMed ID: 16259635
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer Database.
Assi HA; Mukherjee S; Machiorlatti M; Vesely S; Pareek V; Hatoum H
Anticancer Res; 2020 Feb; 40(2):847-855. PubMed ID: 32014928
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in children: epidemiology and the impact of regional lymphadenectomy on surgical outcomes.
McAteer JP; Goldin AB; Healey PJ; Gow KW
J Pediatr Surg; 2013 Nov; 48(11):2194-201. PubMed ID: 24210185
[TBL] [Abstract][Full Text] [Related]
12. Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features.
Malouf GG; Tahara T; Paradis V; Fabre M; Guettier C; Yamazaki J; Long H; Lu Y; Raynal NJ; Jelinek J; Mouawad R; Khayat D; Brugières L; Raymond E; Issa JP
Epigenetics; 2015; 10(9):872-81. PubMed ID: 26224146
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.
Lemekhova A; Hornuss D; Polychronidis G; Mayer P; Rupp C; Longerich T; Weiss KH; Büchler M; Mehrabi A; Hoffmann K
World J Surg Oncol; 2020 May; 18(1):93. PubMed ID: 32397993
[TBL] [Abstract][Full Text] [Related]
14. Results of hepatic resection and transplantation for fibrolamellar carcinoma.
Ringe B; Wittekind C; Weimann A; Tusch G; Pichlmayr R
Surg Gynecol Obstet; 1992 Oct; 175(4):299-305. PubMed ID: 1329242
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for fibrolamellar hepatocellular carcinoma: A national perspective.
Atienza LG; Berger J; Mei X; Shah MB; Daily MF; Grigorian A; Gedaly R
J Surg Oncol; 2017 Mar; 115(3):319-323. PubMed ID: 27878821
[TBL] [Abstract][Full Text] [Related]
16. A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma.
Mavros MN; Mayo SC; Hyder O; Pawlik TM
J Am Coll Surg; 2012 Dec; 215(6):820-30. PubMed ID: 22981432
[TBL] [Abstract][Full Text] [Related]
17. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study.
Sempokuya T; Forlemu A; Azawi M; Silangcruz K; Khoury N; Ma J; Wong LL
World J Clin Oncol; 2022 May; 13(5):352-365. PubMed ID: 35662983
[TBL] [Abstract][Full Text] [Related]
18. Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma.
Groeschl RT; Miura JT; Wong RK; Bloomston M; Lidsky ML; Clary BM; Martin RC; Belli G; Buell JF; Gamblin TC
J Surg Oncol; 2014 Sep; 110(4):412-5. PubMed ID: 24844420
[TBL] [Abstract][Full Text] [Related]
19. Clinical and demographic predictors of survival for fibrolamellar carcinoma patients-A patient community, registry-based study.
Berkovitz A; Migler RD; Qureshi A; Rosemore C; Torbenson MS; Vaughan R; Marcotte E; Simon SM
Hepatol Commun; 2022 Dec; 6(12):3539-3549. PubMed ID: 36245434
[TBL] [Abstract][Full Text] [Related]
20. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.
Schlitt HJ; Neipp M; Weimann A; Oldhafer KJ; Schmoll E; Boeker K; Nashan B; Kubicka S; Maschek H; Tusch G; Raab R; Ringe B; Manns MP; Pichlmayr R
J Clin Oncol; 1999 Jan; 17(1):324-31. PubMed ID: 10458250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
